Extracellular Matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development by Lillien, Laura E. et al.
, Extracellular Matrix-associated Molecules Collaborate with 
Ciliary Neurotrophic Factor to Induce Type-2 Astrocyte Development 
Laura E. Lillien, Michael Sendtner, * and Martin C. Raff 
Medical Research Council Developmental Neurobiology Program, Biology Department, University College London, 
London WCIE 6BT, United Kingdom; 'I< Department of Neurochemistry, Max-Planck Institute for Psychiatry, 
Am Klopferspitz I8a, D-8033 Martinsried, Federal Republic of Germany 
Abstract. 0-2A progenitor cells give rise to both 
oligodendrocytes and type-2 astrocytes in vitro. 
Whereas oligodendrocyte differentiation occurs consti-
tutively, type-2 astrocyte differentiation requires ex-
tracellular signals, one of which is thought to be 
ciliary neurotrophic factor (CNTF). CNTF, however, 
is insufficient by itself to induce the development of 
stable type-2 astrocytes. In this report we show the 
following: (a) that molecules associated with the ex-
tracellular matrix (ECM) cooperate with CNTF to in-
duce stable type-2 astrocyte differentiation in serum-
free cultures. The combination of CNTF and the 
ECM-associated molecules thus mimics the effect of 
FCS, which has been shown previously to induce sta-
ble type-2 astrocyte differentiation in vitro. (b) Both 
the ECM-associated molecules and CNTF act directly 
T HE vertebrate central nervous system (eNS)' devel-ops from the neuroepithelial cells that form the neural tube. These cells give rise to a spectacular diversity 
of nerve cells, as well as to various kinds of supporting (glial) 
cells. The generation of diverse cell types. at specific times 
and locations is thought to depend on interactions between 
cells, although little is known about the nature of the signals 
that presumably mediate these interactions. 
To begin to analyze these signals, we have studied the de-
velopment of a bipotential glial progenitor cell found in the 
rat eNS. It is called the 0-2A progenitor cell because it can 
differentiate in vitro into either an oligodendrocyte, which 
makes myelin in the eNS, or a type-2 astrocyte, whose func-
tions are uncertain (reviewed in Raff, 1989). Studies in 
which antibodies were used to distinguish glial cell types in 
cell suspensions prepared from rat brain and optic nerve at 
different ages suggest that 0-2A progenitor cells differentiate 
in vivo on a characteristic schedule, giving rise to oligoden-
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on 0-2A progenitor cells and can induce them to 
differentiate prematurely into type-2 astrocytes. (c) 
ECM-associated molecules also inhibit oligodendro-
cyte differentiation, even in the absence of CNTF, but 
this inhibition is not sufficient on its own to induce 
type-2 astrocyte differentiation. (d) Whereas the effect 
of ECM on oligodendrocyte differentiation is mim-
icked by basic fibroblast growth factor (bFGF), the 
effect of ECM on type-2 astrocyte differentiation is 
not. (e) The ECM-associated molecules that are 
responsible for inhibitin~ oligodendrocyte differentia-
tion and for cooperating with CNTF to induce type-2 
astrocyte differentiation are made by non-glial cells in 
vitro. (f) Molecules that have these activities and bind 
to ECM are present in the optic nerve at the time 
type-2 astrocytes are thought to be developing. 
drocytes beginning at the time of birth and to type-2 astro-
cytes beginning in the second postnatal week (Abney et aI., 
1981; Miller et al., 1985; WiIliams et al., 1985). This de-
velopmental sequence can be reproduced in cultures of 
perinatal rat brain (WiIliams et aI., 1985; Lillien et al" 
1988) or optic nerve cells (Lillien and Raff, 1990). These 
cultures, therefore, provide experimentally accessible sys-
tems to analyze the environmental signals that control the 
differentiation of 0-2A progenitor cells. Cultures of f,ptic 
nerve cells are especially advantageous because they do not 
contain neurons; in addition to 0-2A lineage cells (oligOden-
drocytes, type-2 astrocytes, and 0-2A progenitor cells), they 
contain several types of non-O-2A lineage cells, mainly 
type-l astrocytes, meningeal cells, macrophages, and en-
dothelial cells. 
The differentiation of 0-2A progenitor cells into oligoden-
drocytes is thought to'Qe the default pathway of development, 
which is triggered automatically when the progenitor cells 
stop dividing (reviewed in Raff, 1989). 0-2A progenitor 
cells are stimulated to proliferate in vitro by PDGF (Noble 
et al., 1988), which is secreted by type-I astrocytes (Rich-
ardson et al., 1988), the first glial cells to develop in the optic 
nerve (Miller et al., 1985). In the absence of PDGF and 
other environmental signals, progenitor cells stop dividing 
h~IY and differentiate exclusively into oligodendro-
cytes (Temple and Raff, 1985; Raff et al., 1988). Even in the 
presence of PDGF, however, 0-2A progenitor cells divide 
only a limited number of times before an intrinsic timing 
mechanism in the cells causes them to stop dividing and 
differentiate into oligodendrocytes (Raff et al., 1988). 
In contrast to oligodendrocyte development, the differenti-
ation ofO-2A progenitor cells into type-2 astrocytes in vitro 
r~uires signals made by other types of cells. If an enriched 
popUlation of 0-2A progenitor cells is cultured in PDGF in 
the absence of serum, for example, oligodendrocytes de-
velop, but type-2 astrocytes do not unless non-O-2A lineage 
cells are added (Lillien and Raff, 1990); the non-O-2A lin-
eage cells presumably provide the required type-2 astrocyte-
inducing signals. There is evidence that one of these induc-
ing signals is CNTF, a 23-kD protein (Manthorpe et al., 
1986), which is made in vitro by type-l astrocytes (Hughes 
et al., 1988; Lillien et al., 1988). The onset oftype-2 astro-
cyte development seems to be regulated, at least in part, by 
the timed production and release of ciliary neurotrophic fac-
tor (CNTF), rather than by the onset of progenitor cell re-
sponsiveness to it (Hughes et al., 1988; Lillien et al., 1988). 
CNTF is not sufficient on its own, however, to induce the de-
velopment of stable type-2 astrocytes: when 0-2A progeni-
tor cells are exposed in vitro to CNTF (Hughes et aI., 1988), 
or to extracts of brain cultures (Lillien et al., 1988) or optic 
nerves (Hughes and Raff, 1987) that contain CNTF (or a 
CNTF-like protein), they are induced to express the astro-
cyte-specific molecule glial fibrillary acidic protein (GFAP; 
Bignarni et al., 1972), but only transiently. This observation 
suggests that additional signals, perhaps nondiffusible, are 
required for stable type-2 astrocyte development. 
We recently reported that stable type-2 astrocytes develop 
in serum-free cultures of newborn optic nerve cells, begin-
ning "'1 wk after the first oligodendrocytes develop, pro-
vided that PDGF is added to the cultures (Lillien and Raff, 
1990). Thus all of the environmental signals required for sta-
ble type-2 astrocyte development must be present in these 
cultures. In the present study we have used these cultures to 
characterize the signals that, in addition to CNTF, are neces-
sary for type-2 astrocyte development. 
Materials and Methods 
Cell Cultures Usedfor Preparing ECM 
Newborn optic nerve cells were dissociated from Sprague-Oawley rats and 
cultured on \3-mm poly-o-Iysine (POL)-coated glass coverslips for 3-15 d 
in serum-free, hormone-supplemented Oulbecco's modified Eagle's medi-
um (SF-OME) as previously described (Lillien and Raff, 1990). In some 
cases the cells were grown in human PDGF (2 nglml; R & 0 Systems, Inc., 
Minneapolis, MN), which was added every 2-3 d. The culture medium was 
changed I d after plating, and half the medium was replaced every 3-4 d. 
Cultures of non-O-2A lineage cells were prepared by treating fresh sus-
pensions of newborn optic nerve cells with mAb A2BS (Eisenbarth et al., 
1979) and anti-galactocerebroside (GC) antibodies in the presence of rabbit 
complement for 45 min at 37°C, as previously described (Lillien and Raff, 
1990). After washing, "'5,000 cells were cultured in SF-OME for 10 d. No 
0-2A lineage cells (oligodendrocytes or 0-2A progenitor cells) were found 
when such cultures were stained for GC and A2BS as described below. 
Cultures enriched for 0-2A lineage cells were prepared by dissociating 
P8 optic nerve cells and culturing "'5,000 cells in SF-OME for 10 d. PDGF 
was added to obtain cultures enriched for both 0-2A progenitor cells and 
oligodendrocytes, but was omitted to obtain cultures enriched mainly for 
oligodendrocytes. • 
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Cultures enriched for type-l astrocytes or meningeal cells were Prepared 
from the cerebral hemispheres of newborn rats as previously described (Lil-
lien et al., 1988). The cells were removed from flasks with trypsin (0.1 %) 
and EmA (0.02 %), and, after washing, "'10,000 cells were plated on PDL-
coated coverslips in OME containing 10% FCS. Cells were either main-
tained in 10% FCS for 10 d or switched to SF-OME 1 d after plating; no 
significant difference was observed in the ECMs prepared from cultures 
grown in the two conditions. 
Cultures of macrophages were prepared from meningeal cell cultures in 
the following way. Flasks of meningeal cells were not fed for 1-2 wk, after 
which time large numbers of macrophages (identified by the presence of 
cell-surface Fe receptors, Raff et al., 1979) appeared on top of the menin-
geal cell monolayer. The macrophages were removed by shaking the flask, 
and 10,000 of them were cultured on POL-coated coverslips in SF-DME 
containing 0.5 % FCS. 
Cultures of bovine aortic endothelial cells (kindly provided by M. Noble, 
Ludwig Institute, London, who obtained the cells from 1. FoI1cman, Har-
Yard Medical School; Vlodavsky et al., 1987) were cultured (after multiple 
passages) on POL-coated coverslips in DME containing 10% calf serum. 
Half of the medium was replaced with SF-OMEM I d after plating and ev-
ery 3-4 d thereafter. 
Matrigel was obtained from Collaborative Research, Inc. (WcIItham, 
MA) and was prepared as a substratum as described by Stemple et al. 
(1988). 
Preparation 0/ ECM 
After the culture medium was aspirated, the cells were removed from the 
coverslips by treatment with 20 mM ammonia containing 0.5 % Triton 
X-lOO for 2-3 min at room temperature, and the coverslips were washed 
in the same solution for another 2-3 min. The ECM was washed twice with 
either ISO mM or 2 M NaCl (in 2 mM phosphate buffer, pH 7.5) for 30 
min and then rinsed repeatedly in DME. The ECM was kept at 37°C and 
used within 3-4 h. Similar results were obtained when the cells were re-
moved with 20 mM ammonia alone. 
Cells Used/or Assaying the Effects o/CNTF and ECM 
Because FCS induces type-2 astrocyte differentiation in vitro (Raff et al., 
1983), we performed all of these experiments in serum-free medium. New-
born and embryonic day 18 (EI8) optic nerve cells were dissociated as previ-
ously described (Raff et al., 1988; Lillien and Raff, 1990), and 3,000-5,000 
cells were cultured in POGF and/or CNTF (2 nglrnl) in SF-OME, either 
on POL-coated coverslips or on ECM-coated coverslips. The CNTF was 
purified from rat sciatic nerve as previously described (Stockli et al., 1989). 
The culture medium was replaced 1 d after plating and fresh POGF and/or 
CNTF was added. The medium change at I d was important because it re-
moved the endogenous CNTF-like activity that is released by the cultured 
cells during the first day in vitro, presumably in response to the dissociation 
procedure (Lillien et aI., 1988). 
Cultures enriched for 0-2A progenitor cells were prepared from P7-9 
optic nerves after partial removal of the meninges. Approximately 20,000-
40,000 cells were cultured on PDL-coated 3S-mm plastic tissue culture 
dishes (Falcon Labware, Oxnard, CA) in SF-OME containing PDGF and 
bovine brain FGF (10 nglrnl; R & 0). M. Noble and his colleagues have 
observed that this combination of growth factors prevents the differentiation 
of 0-2A progenitor cells into oligodendrocytes and keeps them dividing 
(8agler et al., 1990). Culture medium and growth factors were replaced 1 d 
after plating, and fresh POGF and bFGF were added every other day. Cells 
were used within I wk of plating. They were removed from the culture dish 
with trypsin and EmA and then washed; 500-1,000 cells were used in each 
assay culture. At the time the cells were used, "'85 % were 0-2A lineage 
cells, and, of these, 5-20% were GC+ oligodendrocytes. 
Immunofluorescence 
, 
Cultures were fixed in 4 % paraformaldehyde for 5 min at room temperature 
and then double- or triple-stained by indirect immunofluorescence as previ-
ously described (Lillien et al., 1988). Briefly, for triple labeling, the cells 
were first labeled with anti-GC mAb (ascites fluid, 1:100; Ranscht et al., 
1982) followed by class-specific goat anti-mouse IgG3 coupled to fluores-
cein (G anti-MlgG3-Fl; Nordic Immunology, Tilburg, The Netherlands; 
1:100), and then with mAb A2BS (ascites fluid, 1:100; Eisenbarth et al., 
1979) followed by GJlI\ti-mouse immunoglobulin coupled to rhodamine (G 
anti-Mlg-Rd, Cappel Laboratories, Malvern, PA; 1:100); after fixation with 
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acid/alcohol at -20·C for 10 min, the cells were labeled with rabbit anti-
glial fibrillary acidic protein (GFAP) antiserum (1:1,000; Pruss, 1979) fol-
lowed by sheep anti-rabbit Ig-A (Sh anti-Rlg-A; 8urroughs Well come Co., 
Research Triangle Park, NC; 1:1(0). For double labeling, the cells were la-
beled with either A285 or anti-GC antibody followed by G anti-Mlg-Rd and 
then processed for GFAP staining as above. Labeled cultures were examined 
with a Zeiss Universal fluorescence microscope using a 40x objective and 
photographed using Tri-X film (ASA 400) .. 
Microcultures 
6O-well Terasaki plates (Nunc, Roskilde, Denmark) were seeded with either 
newborn optic nerve cells in SF-OME or type-I astrocytes in OME contain-
ing 10% FCS; 1.000 cells were seeded in 10 Ill. ECM was prepared after 
10-14 d as described above. Approximately five enriched 0-2A progenitor 
cells were then added to each microwell in 10 III of SF-OME, containing 
2 ngIm1 CNTF where appropriate. Most microwells contained one to two 
cells. The cells were double-labeled with A285 and anti-GFAP antibodies 
and viewed as previously described (Temple and Raff, 1985). 
Preparation of Optic Nerve Extract in 2 M NaCI 
Extracts of optic nerves from 3-5-wk-old rats were prepared as previously 
described (Hughes and Raff, 1987) except that 2 M NaCI was used. The 
extracts were dialyzed extensively against ISO mM NaCl, centrifuged at 
80,000 g for 30 min to remove material that had precipitated, and then 
stored at -70·C. We refer to this extract as 2M-ONE. 
Adsorption of 2M-DNE, CNTF, and bFGF to 
2 M NaCI-treated ECM 
ECM that had been treated with 2 M NaCI was incubated in OME alone 
or in OME containing 2M-ONE (150-250 Ilglml total protein), CNTF (10 
nglmI), or bFGF (100 nglml) for 3 h at 37·C. The ECM was rinsed in DME 
before enriched 0-2A progenitor cells were added. 
Results 
CNTF-treated 0-2A Progenitor Cells Express GFAP 
Transiently and Then Become Oligodendrocytes 
As reported previously (Hughes et al., 1988), when cells 
from newborn optic nerve were exposed to CNTF, 20-30% 
of the 0-2A progenitor cells (identified by their characteris-
tic morphology and staining with the A2B5 mAb; Temple 
and Raff, 1986) began to express GFAP after 1 d in vitro, 
but, by 3 d in vitro, 0-2A lineage cells expressing GFAP 
were no longer seen (Table I). After 2 d in vitro, >95% of 
the GFAJ» 0-2A lineage cells in such cultures were found 
to express a mixed oligodendrocyte/type-2 astrocyte pheno-
type, being GC+ and GFAP+ (Table I). This finding suggests 
that the cells that are induced by CNTF to express GFAP 
transiently do not die or dedifferentiate into 0-2A progenitor 
cells but instead go on to become oligodendrocytes. 
PDGF Antagonizes the Transient EjJectofCNTF 
We showed previously that stable type-2 astrocytes develop 
in cultures of newborn optic nerve cells grown in serum-free 
medium, but only if PDGF is added to the medium (Lillien 
and Raff, 1990). The requirement for PDGF raised the pos-
sibility that stable type-2 astrocyte differentiation in culture 
might be induced by a combination of CNTF and PDGF. 
When tested directly, however, the combination of CNTF 
~d P.DGF did not induce 0-2A progeniJor cells to differen-
ti~te Into stable type-2 astrocytes; instead, PDGF antago-
ruzed the ability of CNTF to induce progenitor cells to ex-
press GFAP transiently (Table I). This suggests that PDGF 
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Table I. Signals Required/or Stable vs. Transient 
Type-2 Astrocyte Differentiation 
Culture treatment 
CNTF 
CNTF + PDGF 
CNTF + ECM 
0-2A lineage cells 
expressing a type-2 astro-
cyte phenotype (A2B5+, 
GFAP") after 
1 d 
22 ± 2 
6±2 
38 ± 5 
2 d 
% 
14 ± 3 
NO 
NO 
3d 
o 
2 ± 1 
79 ± 5 
GFAP" 0-2A lineage 
cells e~ a mixed 
0ligodendrocyteltype-2 
astrocyte phenotype 
(GC) after 
Id 
5 ± 5 
NO 
NO 
2d 
% 
96 ± 4 
NO 
NO 
3d 
NO 
NO 
o 
Newborn optic nerve cells were cultured for 1-3 d and then double-Iabeled 
with either A2B5 and anti-GFAP or anti-GC and anti-GFAP antibodies. The 
ECM was prepared from 9-12-d-old cultures of newborn optic nerve cells. 
0-2A lineage cells were recognized by their antigenic phenotype (A2B5+) 
andIor their characteristic process-bearing morphologies. In the absence of 
CNTF and ECM, <I % of the 0-2A lineage cells expressed GFAP after I, 2, 
and 3 d in vitro. In this and in Tables ll, m, and V the results are expressed 
as means ± SE of at least three experiments. 
is required for type-2 astrocyte development in serum-free 
cultures of newborn optic nerve cells only because it keeps 
0-2A progenitor cells proliferating (and thereby prevents 
their premature differentiation into oligodendrocytes) until 
endogenous type-2 astrocyte-inducing signals are produced 
by the cultured ceIls. 
A Combination ofCNTFand 
ECM-associated Molecules Induces Stable Type-2 
Astrocyte DijJerentiatio'! In Vitro 
Although stable type-2 astrocytes develop after 8-10 d in 
serum-free cultures of newborn optic nerve cells in the pres-
ence of PDGF (Lillien and Raff, 1990), supernatants pre-
pared from these cultures at this time only induce 0-2A pro-
genitor cells in vitro to express GFAP transiently rather than 
to develop into stable type-2 astrocytes (unpublished obser-
vations). The same is true for supernatants prepared from 
embryonic brain cell cultures (Lillien and Raff, 1988) and 
for saline extracts prepared from such cultures (LiIlien et al., 
1988) and from optic nerve (Hughes and Raff, 1987), all at 
the time type-2 astrocytes are developing. These findings 
suggest that diffusible signals are not sufficient to induce sta-
ble type-2 astrocyte differentiation. We therefore looked for 
Table 11. 0-2A Progenitor Cells Respond Prematurely 
to Type-2 Astrocyte-inducing Signals , 
Age of rats 
EI8 
EI8 
Newborn 
Newborn 
Culture treatment 
ECM + CNTF 
ECM + CNTF + PDGF 
ECM + CNTF 
ECM .+. CNTF + PDGF 
.. 
0-2A lineage cells 
expressing a type-2 
astrocyte phenotype 
after 3-4 d in vitro 
% 
100 
100 
79 ± 5 
61 ± 3 
Optic nerve cells from newborn or embryonic day IS (EIS) rats were cultured 
on ECM prepared from 1O-d-old cultures of newborn optic nerve cells. The 
cultures were triple-Iabeled with anti-GC, A2B5, and anti-GFAP antibodies. 
A type-2 astrocyte phenotype was defined as a process-bearing cell that was 
A2B5+ and GFAP+. 
Figure 1. Immunofluorescence micrographs oftype-2 astrocytes induced by CNTF and ECM. Enriched 0-2A progenitor cells were cultured 
in CNTF for 6 d on ECM prepared from l4-d-old cultures of newborn optic nerve cells. Cells in two cultures are shown: in one the cells 
were labeled for A2B5 (a) and GFAP (b); in the other the cells were labeled for GC (c) and GFAP (d). Note that the type-2 astrocytes 
are A2BS', GFA?'" , and GC, whereas the GC- oligodendrocyte shown in c is GFAP- (d). Bar, 25 /lm. 
a nondiffusible inducing signal in cultures of newborn optic 
nerve cells grown in vitro for 9-15 d, a time when stable 
type-2 astrocytes were found to develop in these cultures 
(Lillien and Raff, 1990). We began by testing the ECM pro-
duced by these cultures; although we shall follow the conven-
tional practice of using the term ECM to refer to the material 
left behind on the culture dish after the cells were removed 
with ammonia and Triton X-lOO, we cannot exclude the pos-
sibility that the relevant signalling molecules were associated 
with residual cell fragments. 
When cells from newborn optic nerve were cultured in the 
presence of CNTF on ECM prepared from cultures of new-
born optic nerve cells, the majority of 0-2A progenitor cells 
differentiated into stable, GC- type-2 astrocytes by 3 d in 
vitro (Table I). If, instead of CNTF, a saline extract of 3-4-
wk-old optic nerve (Hughes and Raff, 1987) was used in 
combination with ECM, similar results were observed (not 
shown). Even after 1 d in vitro, more 0-2A lineage cells ex-
pressed GFAP when they were exposed to both ECM and 
CNTF than when they were exposed to CNTF alone (Table 
I). When cells from embryonic day 18 (EI8) optic nerves 
were cultured on ECM in the presence of CNTF, all of the 
• 
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0-2A progenitors differentiated into type-2 astrocytes by 3 d 
in vitro (Table II), indicating that 0-2A progenitor cells are 
responsive to both CNTF and ECM long before they nor-
mally differentiate into type-2 astrocYles. Whereas PDGF 
strongly antagonized the transient effects of CNTF alone (see 
Table I), it antagonized the effects of the combination of 
CNTF and ECM only weakly or not at all (Table II). 
CNTF and ECM Act Directly on 0-2A Progenitor 
Cells to Induce Type-2 Astrocyte Development 
To study further the signal associated with the ECM made 
by optic nerve cultures and to identify its cellular source, we 
used an enriched population of 0-2A progenitor cells as test 
cells. These cells were prepared from optic nerve J:ultures 
that had been maintained in the continuous presence of 
PDGF and bFGF. For the most part, these enriched 0-2A 
progenitor cells responded to CNTF and ECM in the same 
way as 0-2A progenitor cells in cultures of perinatal optic 
nerve cells: when cultured on ECM in the presence of CNTF 
for 3 or 6 d, the majority differentiated into GC-, A2BY, 
GFAP+ type-2 astrocytes (Fig. I and Table III), whereas 
when cultured 0.11 ECM without CNTF, or in CNTF without 
638 
Table /11. Responses of Enriched 0-2A Progenitor Cells 
to CNTF and.ECM 
Substratum 
POL 
POL 
ECM 
ECM 
CNTF 
+ 
+ 
0-2A lineage cells expressing a 
type-2 astrocyte phenotype after 
Id 3d 6d 
% 
0 0 NO 
4 ± I 0 NO 
<I <I NO 
42 ± 9 63 ± 6 91 ± I 
Enriched 0-2A progenitor cells were cultured on POL or on ECM that was 
prepared from 9-12-d-old cultures of newborn optic nerve cells. After I~ d, 
the cultures were triple-Iabeled as in Table 11. or double-Iabeled with anti-GC 
and anti-GFAP antibodies. and type-2 astrocytes were identified either as 
A28S+' GFAP+ process-bearing cells. or as GC-. GFAp· process-bearing 
cells. respectively. The results were not significantly different with the two 
staining procedures. 
ECM, the cells that differentiated developed into oligoden-
drocytes and not type-2 astrocytes (Table III; see Fig. 2). The 
enriched 0-2A progenitor cells differed from progenitor 
cells in cultures of perinatal optic nerve, however, in that few 
of them responded even transiently to CNTF in the absence 
of ECM, although many responded within 24 h to CNTF in 
the presence of ECM (Table Ill). 
To detennine whether CNTF and the ECM-associated 
Table IV. Effect ofCNTF and ECM on Single 0-2A 
Progenitor Cells 
ECM prepared 
from cultures of 
Optic nerve cells 
Optic nerve cells 
Type-I astrocytes 
CNTF 
+ 
+ 
Fraction of 0-2A 
lineage cells 
expressing a 
type-2 astrocyte 
phenotype 
after 3 d 
0/42 
641117 
0/97 
Individual 0-2A progenitor cells were added (by limiting dilution) to micro-
wells containing ECM produced by either newborn optic nerve cells or type-I 
astrocytes. The cells were double-Iabeled with A285 and anti-GFAP antibod-
ies. On average, there were 1.5 cells/well; 32 of the wells with optic nerve cell 
ECM contained a single 0-2A lineage cell as the only visible cell in the well. 
and J1 of these were GFAP+. 
molecules act directly on 0-2A progenitor cells, rather than 
indirectly via other cell types, we cultured individual pro-
genitor cells in microwells for 3 d. As shown in Table IV, 
isolated 0-2A progenitor cells cultured on ECM prepared 
from newborn optic nerve cell cultures developed into type-2 
astrocytes in the presence, but not in the absence, of CNTF. 
Thus both CNTF and the ECM-associated molecules act 
directly on 0-2A progenitor cells to induce type-2 astrocyte 
differentiation. 
2 M NaCl- % 0-2A lineage cells expressing 
treated GC after 3 d compared to that 
ECM ECM Cultured seen Qn POL alon~ 
treated incubated for 3 d 
Sl!lmrnlum ~ for 3 h with ~ so 75 
(a) POL 
(b) POL CNTF 
(c) ONECM untreated 
(d) ONECM untreated CNTF 
(e) Meningeal untreated CNTF 
cell ECM 
(f) Endothelial untreated Figure 2. ECM-associated sig-
cell ECM 
nals that inhibit oligodendrocyte 
(g) Type-I untreated differentiation. Enriched 0-2A 
astrocyte progenitor cells were cultured on 
ECM POL or ECM for 3 d and then tri-
(h) ONECM I M NaCI CNTF ple-labeled for GC, A2B5, and GFAP. The proportion of ()-2A 
(i) ONECM 2 M NaCI CNTF lineage cells that differentiated 
into GC+ oligodendrocytes was 
(j) ONECM 2 M NaCI determined and compared to that 
seen when the cells were cultured (k) ONECM 2 M NaCI 2M-ONE on POL alone. More than 95 % of 
(I) POL 2M-ONE the 0-2A lineage cells were GC+ 
when cultured on POL alone. 
(m) Type-I 2 M NaCI 2M-ONE In this and the following figure, 
astrocyte .... ·w ECM was prepared from 9-12-<1-
ECM old cultures, and the results are 
(n) • expressed as means ± SE of at ONECM 2 M NaCI bFGF least three experiments. ON, op-
tic nerve. 
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Table V. Cellular Sources of the Nondiffusible Type-2 Astrocyte-inducing Signal 
0-2A lineage cells 
0-2A lineage expressing a type-2 
ce':s expressing astrocyte phenotype 
a type-2 astrocyte after 3 d compared 
phenotype with that seen with 
Substratum after 3 d 9-12 d ON ECM 
ECM from newborn ON cells 63 ± 6 100 
+ 9-12 d in vitro 
ECM from newborn ON cells 4 ± 1 7 
+ 4 d in vitro 
Newborn ON cells + 12 d in vitro 89 ± 1 140 
ECM from non-O-2A lineage 53 ± 3 110 
cells of newborn ON 
ECM from meningeal cells 42 ± 4 95 
ECM from type-I astrocytes 0 0 
ECM from meningeal macrophages 0 0 
ECM from oligodendrocytes 0 0 
ECM from oligodendrocytes plus 0 0 
0-2A progenitor cells 
Matrigel 0 0 
ECM from bovine aonic 72±1O 104 
endothelial cells 
Enriched 0-2A progenitor cells were grown in the presence of CNTF on POL. ECM prepared from various types of cells. or on unextracted cultures of newborn 
optic nerve cells. Except where indicated. ECM was prepared from 9-12-d-old cultures. After 3 d. the cells were triple-Iabeled for GC. A2B5. and GFAP and 
the proportion of 0-2A lineage cells that differentiated into A2B5" GFAP+ type-2 astrocytes was determined and compared with that seen with cells cultured 
in CNTF on ECM prepared from 9-12-d-old cultures of newborn optic nerve cells. which varied between 35 and 93% in different experiments. ON. optic nerve. 
Not All Cell Types Make the Relevant 
ECM-associated Molecules 
In the experiments described so far, ECM was prepared from 
newborn optic nerve cell cultures that were maintained, with 
or without PDGF, in the absence of serum for 9-15 d (the 
presence or absence of PDGF did not affect the activity of 
the ECM [not shown]). ECM prepared from similar cultures 
but after only 3-4 d in vitro was much less effective in induc-
ing stable type-2 astrocyte differentiation (Table V). Intact 
cells from 12 d-old cultures of newborn optic nerve cells 
(which were grown without PooF and, therefore, did not 
contain type-2 astrocytes) were at least as effective as the 
ECM prepared from such cultures (Table V); in these cul-
tures, many of the type-2 astrocytes that developed after the 
addition of enriched 0-2A progenitor cells did not appear to 
be in contact with other cells, suggesting that the nonditfusi-
ble signalling molecules are associated with the ECM and 
not just with cell surfaces. This finding also suggests that the 
active components in the ECM are normally extracellular 
and not merely released from intracellular sites as a result 
of the cell removal procedure used to prepare the ECM. 
To begin to identify the cellular source(s) of the ECM-
associated molecules, we first eliminated the 0-2A lineage 
population from newborn optic nerve cells by treatment with 
A2B5 and anti-GC antibodies in the presence of rabbit com-
plement. ECM prepared from such cultures of non-O-2A 
lineage cells was as active as that prepared from cultures of 
unfractionated newborn optic nerve cells (Table V). This 
non-O-2A lineage popUlation contains mainly type-l astro-
cytes and meningeal cells, but also some endothelial cells 
and macrophages. When cultures enriched for specific types 
of non-O-2A lineage cells were tested, ECM from meningeal 
cells was found to support stable type-2 astrocyte differentia-
• 
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tion in the presence of CNTF, whereas ECM from cultures 
of cortical type-I astrocytes (Tables IV and V) or of menin-
geal macrophages (Table V) was not effective. ECM pre-
pared from cultures enriched for 0-2A lineage cells (either 
oligodendrocytes or oligodendrocytes plus 0-2A progenitor 
cells) were also ineffective, as was Matrigel, an ECM prepa-
ration from mouse sarcoma cells (Table V). ECM prepared 
from cultures of multiply passaged bovine aortic endothelial 
cells was as effective as ECM from meningeal cultures and 
newborn optic nerve cells (Table V). These results suggest 
that the ECM-associated molecules that collaborate with 
CNTF to induce type-2 astrocyte development are made by 
nonglial cells. 
ECM-associated Molecules Inhibit Oligodendrocyte 
Differentiation Even in the Absence ofCNTF 
In all of the cases we tested, ECM did not induce type-2 astro-
cyte differentiation unless CNTF was added to the cultures 
(see Table 1lI, for example). All of the ECMs that collabo-
rated with CNTF to induce type-2 astrocyte differentiation, 
however, inhibited the differentiation of 0-2A progenitor 
cells into oligodendrocytes even without the addition ofFNTF. 
Whereas in the absence of ECM >95 % of 0-2A progenitor 
cells differentiated into GC+ oligodendrocytes within 3 d in 
vitro (Fig. 2 a), in the presence ofECM prepared from optic 
nerve cultures (and in the absence of CNTF) , <30% ofO-2A 
progenitor cells differentiated into oligodendrocytes within 
3 d (Fig. 2 c). ECM made by meningeal cells and endothelial 
cells also inhibited oligodendrocyte differentiation (Fig. 2, e 
and f), whereas ECM prepared from type-I astrocyte cul-
tures did not (Fig:-2.g). CNTF, in the absence of ECM, did 
not inhibit oligodendrocyte differentiation (Fig. 2 b) . 
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ECM Activity Is Removed by Treatment with 2 M NaCI 
To begin to characterize the signaling molecules associated 
with the ECM made by optic nerve cell cultures, we tried to 
remove the molecules by treating the ECM with increasing 
concentrations of NaC!. Whereas treatment with 0.5 M NaCI 
had little if any effect (Fig. 3 b), treatment with 1 M NaCl 
removed approximately half of the type-2 astrocyte-inducing 
activity (Fig. 3 c), but had no effect on the ability of the ECM 
to inhibit oligodendrocyte differentiation (Fig. 2 h). Treat-
ment with 2 M NaCl removed 60-80% of both activities 
(Figs. 2j and 3 d), as did 3 M NaCl (not shown). Both the 
type-2 astrocyte-inducing (Fig. 3 e) and oligodendrocyte-
inhibiting activities (Fig. 2 k) were restored if the salt-treated 
ECM was incubated with an extract of optic nerves from 
3-4-wk-old rats made in 2 M NaCl. This optic nerve extract 
(2M-ONE) did not induce stable type-2 astrocyte differentia-
tion when applied in the absence of the 2 M NaCI-treated 
ECM, even in the presence of extra CNTF (Fig. 3 f), al-
though it did inhibit oligodendrocyte differentiation in the 
absence ofECM (Fig. 21). Thus type-2 astrocyte differentia-
tion requires the combination of CNTF and 2 M NaCl-
extractable molecules in ECM, which must either be bound 
to the ECM to act or be presented in combination with an 
additional ECM-associated signal that is not extracted by 
2 M NaCI. Surprisingly, 2M-ONE was not able to activate 
either Matrigel or ECM prepared from cultures of type-l as-
trocytes to collaborate with CNTF to induce type-2 astrocyte 
differentiation (Fig. 3, h and i). 2 M NaCI-treated type-l as-
trocyte ECM, however, could be activated by 2M-ONE to in-
hibit oligodendrocyte differentiation (Fig. 2 m). CNTF itself 
did not bind in an active fonn to ECM prepared from optic 
nerve cultures, whether or nOt the ECM was first treated with 
2 M NaCl (Fig. 3 j), excluding the possibility that the ECM 
~cts simply to concentrate or present CNTF to 0-2A progen-
Itor cells. 
If2 M NaCI-treated ECM prepared from optic nerve cul-
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% 0-2A lineage cells expressing 
a type-2 astrocyte phenotype 
after 3 d compared to that seen 
with QN J;;QM ~Iu~ QNTF 
r 
25 so 75 100 Figure 3. Removing and recon-
stituting ECM-associated signals 
that induce type-2 astrocyte dif-
ferentiation in the presence of 
CNTF. Enriched 0-2A progeni-
tor cells were cultured for 3 d and 
then either double-Iabeled for GC 
and GFAP or triple-Iabeled for 
GC, A2B5, and GFAP. The pro-
portion ofO-2A lineage cells that 
differentiated into cells with a 
type-2 astrocyte phenotype (pro-
cess-bearing cells that were either 
A2B5+, GFAP", or GC-, GFAP") 
was determined and compared 
with that seen with cells cultured 
on ON ECM (prepared from 9-
12-d-old cultures of newborn op-
tic nerve cells) in the presence of 
CNTF, which varied between 35 
and 93 % in different experiments. 
tures was incubated in 100 nglml of bFGF, its ability to in-
hibit oligodendrocyte differentiation was completely re-
stored (Fig. 2 n). This concentration of bFGF, however, did 
not restore the ability of salt-washed ECM to collaborate 
with CNTF in inducing type-2 astrocyte differentiation, even 
when the bFGF was continuously present in the culture 
(Fig. 3 k). 
Discussion 
Previous studies suggested that CNTF is only one part of a 
system of extracellular inducing signals required for the de-
velopment oftype-2 astrocytes (Hughes et al., 1988; Lillien 
et aI., 1988). We have now shown that 0-2A progenitor cells 
can be induced to differentiate in vitro into stable type-2 as-
trocytes by a combination of CNTF and a nondiffusible sig-
nal that is associated with the extracellular matrix produced 
by cultures of optic nerve cells. Single-cell experiments indi-
cate that both signals act directly on 0-2A progenitor cells. 
The ECM-associated signal has two effects on 0-2A progen-
itor cells: it promotes type-2 astrocyte differentiation, and it 
inhibits oligodendrocyte differentiation. Whereas the first 
effect requires CNTF, the second does not. 
TIming Mechanism of Type-2 Astrocyte Development 
The development ofO-2A progenitor cells into oligodendro-
cytes appears not to require environmental inducing signals 
(Temple and Raff, 1985). Both the choice and timing of 
oligodendrocyte development seem to depend instead on an 
intrinsic mechanism that limits progenitor cell proliferation 
in response to pp...9F; oligodendrocyte differentiation is 
thought to follow automatically as a consequence of the pro-
genitor cell's withdrawal from the cell cycle (Raff et al., 
1988; Hart et aI., 1989). 
Type-2 astrocytes, like oligodendrocytes, begin to differ-
entiate on a predictable schedule both in vivo (Miller et al., 
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1985; Williams et aI., 1985) and in vitro (Williams et aI., 
1985; Lillien et al., 1988; Lillien and Raff, 1990). In princi-
ple, the timing of type-2 astrocyte development could reflect 
the timed production of inducing signals (environmental con-
trol), the timed responsiveness to these signals (intrinsic 
control), or both. Previous work demonstrated that 0-2A 
progenitor cells can respond prematurely, although transiently, 
to CNTF (Hughes et al., 1988). In this study we have shown 
that perinatal 0-2A progenitor cells can respond to the com-
bination of CNTF and ECM by differentiating into stable 
type-2 astrocytes at least a week before they normally would 
do so in vivo. This combination oftype-2 astrocyte-inducing 
signals is not inhibited by PDGF, although, in the absence 
of exogenous ECM, PDGF antagonizes the transient response 
to CNTF. These and previous observations (Hughes and 
Raff, 1987; Hughes et al., 1988; Lillien et al., 1988; Lillien 
and Raff, 1990) suggest that 0-2A progenitor cells are respon-
sive to type-2 astrocyte-inducing signals before the cells 
reach an intrinsic proliferation limit and that the timing of 
type-2 astrocyte development depends exclusively on when 
the inducing signals appear. In previous studies it was shown 
that the production of CNTF in the developing optic nerve 
(Hughes et aI., 1988) and in cultures of brain cells (Lillien 
et al., 1988) coincides with the development of type-2 astro-
cytes. In this study we found that the signal associated with 
the ECM also increases with time in cultures of newborn op-
tic nerve cells. It is not clear whether this increase results 
from the timed production of the signal or from the steady 
accumulation of the signal with time in vitro; in either case, 
it probably contributes to the timing of type-2 astrocyte de-
velopment in optic nerve cultures. We have not yet deter-
mined when the ECM -associated signal first appears in the 
developing optic nerve. 
Cellular Source of the ECM-associated Signal 
The differentiation of 0-2A progenitor cells into type-2 as-
trocytes in vitro was previously shown to require non-O-2A 
lineage cells (Lillien and Raff, 1990), which, in optic nerve 
cultures, include type-l astrocytes, meningeal cells, macro-
phages, and endothelial cells. This observation is now ex-
plained as non-O-2A lineage cells appear to be the source 
of both CNTF and the ECM-associated signal, at least in 
vitro. Type-l astrocytes were previously shown to be a 
source ofCNTF (Lillien et al., 1988), but this study suggests 
that they do not make the ECM-associated inducing signal: 
ECM produced by cultures of cortical type-l astrocytes did 
not induce type-2 astrocyte differentiation in the presence of 
CNTF. Whereas ECM produced by cultures of macrophages 
or 0-2A lineage cells was also ineffective at inducing type-2 
astrocyte development in the presence of CNTF, ECM pro-
duced by cultures of cerebral meningeal cells or bovine aor-
tic endothelial cells was as effective as ECM produced by 
cultures of mixed optic nerve cells. The meningeal cultures 
were morphologically heterogeneous and might well have 
contained endothelial cells, as the meninges used to prepare 
the cultures were rich in blood vessels. It remains to be de-
termined whether CNS endothelial cells also produce the 
ECM-associated type-2 astrocyte-inducing signal, and whether 
these cells are the source of the signal in vivo. As meningeal 
cultures were found previous!>' not to produce CNTF-like 
activity (Lillien et al., 1988), It seems that at least two types 
~ 
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of non-O-2A lineage cells must collaborate to induce type-2 
astrocyte development in vitro. 
Nrtureofthe ECM-associated Signal 
There are nu~erous reports of the influence of ECM compo-
nents on the growth and differentiation of a variety of cell 
types; some of these effects are mediated by the structural 
components of the ECM itself (for example, Panayotou et 
al., 1989; Adams and Watt, 1989), whereas others are medi-
ated by signalling molecules bound to the ECM (for exam-
ple, Vlodavsky et al., 1987; Baird and Ling, 1987; Gordon 
et al., 1987; Rogelj et al., 1989). The functional significance 
of ECM-bound signaling molecules is not clear. In the case 
of bFGF, which is active in a soluble state, association with 
the ECM has been reported to stabilize the protein (Gospo-
darowicz and Cheng, 1986; Saksela et al., 1988), and it has 
been suggested that ECM might serve as a storage site for 
FGF (Baird and Ling, 1987; Vlodavsky et al., 1987). Treat-
ment of ECM with high concentrations of NaCI causes bound 
factors such as bFGF to dissociate (Baird and Ling, 1987; 
Vlodavsky et al., 1987), and it might also release some in-
trinsic matrix components as well (for example, Lindahl and 
Hook, 1978; Timpl and Rohde, 1979). Although we referto 
the nondiffusible signal that influences 0-2A progenitor cell 
development as ECM associated, many ECM-associated mol-
ecules are also bound to cell surfaces, and we cannot exclude 
the possibility that the nondiffusible signal we have studied 
is also cell-surface associated. We found that when 0-2A 
progenitor cells were grown (in the presence of CNTF) on 
12-d-old cultures of newborn optic nerve cells, rather than 
on ECM prepared from such cultures, many of the type-2 as-
trocytes that developed were located entirely on the substra-
tum between the optic nerve cells. This finding suggests that 
the nondiffusible signal that collaborates with CNTF to in-
duce type-2 astrocyte differentiation is not exclusively asso-
ciated with cell surfaces. By contrast, studies of a nondiffusi-
ble signal made by 3T3 cells that stimulates the proliferation 
and development of hemopoeitic stem cells have shown that 
the stem cells respond only when in contact with the 3T3 
cells and not when located on the ECM produced by these 
cells (Roberts et al., 1987). 
To begin to characterize the ECM-associated molecules 
that inhibit oligodendrocyte differentiation and act in con-
junction with CNTF to induce type-2 astrocyte differentia-
tion, we treated ECM made by optic nerve cultures with 2 M 
NaCl. This treatment largely removed both the type-2 astro-
cyte-inducing activity and the oligodendrocyte differentia-
tion inhibiting activity. Both activities were restored by incu-
bation of the salt-treated ECM with an extract of optic nerve 
made in 2 M NaCl. This finding suggests that the nondiffusi-
ble signal, like CNTF (Hughes et al., 1988), is present in 
the optic nerve at the time type-2 astrocytes are deviloping. 
Does the same ECM-associated molecule both induce 
type-2 astrocyte differentiation and inhibit oligodendrocyte 
differentiation? Four findings suggest that the two activities 
are mediated by different molecules. (a) When ECM pro-
duced by cultures of newborn optic nerve cells was treated 
with 1 M NaCl, much more type-2 astrocyte-inducing activ-
ity was removed than oligodendrocyte-inhibiting activity. (b) 
The active come9.!lent(s) in 2 M NaCI extracts of optic nerve 
appears to have to be associated with ECM to induce type-2 
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astrocyte differentiation but not to inhibit oligodendrocyte 
differentiation. (c) The addition of bFGF to 2 M NaCl-
washed ECM reconstituted the ability of the ECM to inhibit 
oligodendrocyte differentiation, but it did not reconstitute the 
. ability of the ECM to collaborate with CNTF to induce type-
2 astrocyte differentiation. (d) Whereas ECM made by type-
1 astrocyte cultures expressed neither activity, treatment of 
this ECM with 2 M NaCI extracts of optic nerve conferred 
oligodendrocyte inhibiting activity but not type-2 astrocyte-
inducing activity. A parsimonious interpretation of these 
findings is that bFGF, or a related protein, is responsible for 
the oligodendrocyte inhibitory effect of the ECM while a 
different molecule is responsible for the type-2 astrocyte-
inducing effect. Preliminary observations indicate that the 
ECM-associated type-2 astrocyte-inducing activity is sensi-
tive to trypsin but not to collagenase, suggesting that the rele-
vant signaling molecule is itself a noncollagenous protein, or 
is bound to such a protein. 
Mechanism of Action of 
the ECM-associated Molecules 
The presence of ECM appears to change the response of . 
perinatal 0-2A progenitor cells to CNTF from a transient 
to a stable one. Several observations, however, suggest that 
even the transient response to CNTF requires some ECM. 
When enriched 0-2A progenitor cells were exposed to 
CNTF for 24 h, few responded in the absence of ECM, al-
though many responded in the presence of ECM. By con-
trast, 20-30% of the 0-2A progenitor cells in cultures of 
newborn optic nerve responded transiently to CNTF in the 
absence of exogenous ECM, although many more responded 
in the presence of ECM. As newborn optic nerve cultures 
contain a high proportion of non-O-2A lineage cells (Lillien 
and Raff, 1990), which are the source of the ECM-associated 
signals, it is possible that these cells produce enough ECM 
to support a transient response to CNTF but not enough to 
support a stable response. A correlation between the propor-
tion ofnon-O-2A lineage cells present and the degree oftran-
sient response to CNTF was observed previously (although 
its significance was not recognized): the transient response 
to CNTF was found to be lower in cultures of P7 optic nerve 
cells, which contain relatively few non-O-2A lineage cells, 
than in cultures of perinatal optic nerve cells, which contain 
many such cells (Hughes and Raff, 1987). 
There are other instances where the combination of 
diffusible and non-diffusible extracellular signals are re-
quired for a cellular response. For example, the response of 
blood neutrophils to tumor necrosis factor requires an 
integrin-mediated interaction with ECM proteins (Nathan et 
al., 1989), and the survival of embryonic sensory neurons 
in vivo is promoted by the combination of brain -derived neu-
rotrophic factor and laminin, but not by brain-derived neuro-
trophic factor alone (Kalcheim et al., 1987). In neither of 
these cases is the mechanism of the collaboration under-
stood. Similarly, it is not clear how CNTF and the ECM-
associated molecules collaborate to induce type-2 astrocyte 
development, although it is. clear that the ECM does not sim-
ply bind CNTF and present it to 0-2A progenitor cells, as 
we could not detect CNTF activity ijl ECM even after the 
ECM was treated with exogenous CNTF. Our finding that 
ECM inhibits oligodendrocyte differentiation but does not 
Lillien et al. ECM-associated ASlrocyte-inducing Signals 
induce type-2 astrocyte development in the absence of CNTF 
demonstrates that the inhibition of the default pathway of 
0-2A progenitor cell development is not sufficient on its own 
to induce type-2 astrocyte differentiation; positive inducing 
signals are still required. It is possible, however, that the in-
hibition of oligodendrocyte differentiation is an essential part 
of the induction process. 
The most important conclusion of this study is that both 
CNTF and ECM-associated molecules are required to in-
duce 0-2A progenitor cells to develop into type-2 astrocytes 
in serum-free cultures. It is not known whether, in inducing 
stable type-2 astrocyte development in vit~, FCS mimics 
the effects of these diffusible and nondiffusible signals, or 
whether it induces their production or release; previous 
single-cell experiments suggest that FCS can act both directly 
and indirectly on progenitor cells to induce them to differen-
tiate into type-2 astrocytes (Temple and Raff, 1985). It is also 
uncertain how our findings in vitro relate to glial cell differ-
entiation in vivo; it is clear, however, that both signals re-
quired for type-2 astrocyte development in vitro are present 
in the optic nerve at the time type-2 astrocytes are thought 
to be developing. 
We thank M. Noble and J. Folkman for the bovine aortic endothelial cells 
and I. Mason. A. Mudge. and J. Voyvodic for helpful comments on the 
manuscript. L. E. Lillien was supported by the American Multiple Sclero-
sis Society and by the Wellcome Trust. . 
Received for publication 14 March 1990 and in revised form I May 1990. 
References 
Abney. E. R .• P. P. Bartlett. and M. C. Raff. 1981. Astrocytes. ependymal 
cells. and oligodendrocytes de~elop on schedule in dissociated cell culrures 
of embryonic rat brain. Dev. diol. 83:301-310. 
Adams. J. F .. and F. M. Watt. 1989. Fibronectin inhibits the terminal differen-
tiation of human keratinocytes. Nature (Lond.). 340:307-309. 
Baird. A .• and N. Ling. 1987. Fibroblast growth factors are present in the ex-
tracellular matrix produced by endothelial cells in vitro: implications for a 
role of heparinase-Iike enzymes in the neovascular response. Biochem. Bio-
phys. Res. Commun. 142:428-435. 
Bignami. A .. L. F. Eng. D. DahI. and C. T. Uyeda. 1972. Localization of the 
glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain 
Res. 43:429-435. 
BOgler. 0 .• D. Wien. S. C. Bamett. H. Land. and M. Noble. 1990. Coopera-
tion between two growth factors promotes extended self-renewal and inhibits 
differentiation of 02-A progenitor cells. Proc. NaIl. Acad. Sci. USA. In 
press. 
Bottenstein. J. E .• and G. H. SalO. 1979. Growth of a rat neuroblastoma cell 
line in serum-free supplemented medium. Proc. NaIl. Acad. Sci. USA. 
76:514-517. 
Eisenbarth. G. S .• F. S. Walsh. and M. Nirenburg. 1979. Monoclonal antibody 
to a plasma membrane antigen of neurons. Proe. Natl. Acad. Sei. USA. 
76:4913-4917. 
Gordon. M. Y .• G. P. Riley. S. M. Watt. and M. F. Greaves. 1987. Compart-
mentalization of a haematopoietic growth factor (GM-CSF) by glycosarnino-
glycans in the bone marrow microenvironment. Nature (Lond.). 326:403-
~. . 
Gospodarowicz. D .• and]. Cheng. 1986. Heparin protects basic and acidic FGF 
from inactivation. J. Cell. Physiol. 128:475-485. 
Hart. I. K .• w. D. Richardson. S. R. Bolsover. and M. C. Raff. 1989. PDGF 
and intracellular signaling in the timing of oligodendrocyte differentiation. 
J. Cell Bioi. 109:3411-3417. 
Hughes. S. M .• and M. C. Raff. 1987. An inducer protein may control the tim-
ing of fate switching in a bipotential glial progenitor cell in the rat optic 
nerve. Development. 101:157-167. 
Hughes. S. M .• L. E. Lillien. M. C. Raff. H. Rohrer. and M. Sendtner. 1988. 
Ciliary neurotrophic factor induces type-2 astrocyte differentiation in cul-
rure. Nalure (Lond). 325:70-73. 
Kalcheim. C .• Y. A. Blfd'~H. Thoencn. and N. M. LcDouarin. 1987. In vivo 
effect of brain-derived neurotrophic factor on the survival of developing dor-
sal root ganglion cells. EMBO (Eur. Mol. Bioi. Organ.) J. 6:2871-2873. 
Lillien. L. E .• and M. C. Raff. 1990. Analysis of the cell-cell interactions that 
control type-2 astrocyte development in vitro. Neuron. In press. 
Lillien. L. E .• M. Sendtncr. H. Rohrer. S. M. Hughes. and M. C. Raff. 1988. 
643 
.,. 
, Type-2 astrocyte development in rat brain cultures is initiated by a CNTF-
. like protein produced by type-I astrocytes. Nl!uron. 1:485-494. 
LI~I. U .• and M. Hook. 1978. Glycosaminoglycans and their binding to bio-
logical macromolecules. Annu. Rl!v. Biochl!m. 47:385-417. 
Manthorpe. M .• S. D. Skaper. L. R. Williams. and S. Varon. 1986. Purification 
of adult rat sciatic nerve ciliary neuronotrophic factor. Brain. Res. 
367:282-286. 
Miller. R. H .• S. David. R. Patel. E. R. Abney. and M. C. Raff. 1985. A quan-
titative immunohistochemical study of macroglial cell development in the rat 
optic nerve: in vivo evidence for two distinct astrocyte lineages. Dl!v. Bioi. 
III :35-41. 
Nathan. C .• S. Srimal. C. Farber. E. Sanchez. L. Kabbash. A. Asch. J. Gailit. 
and S. D. Wright. 1989. Cytokine-induced respiratory burst of human neu-
trophils: dependence on extracellular matrix proteins and CDII/CDI8 inte-
grins. J. CI!{( Bioi. 109:1341-1349. 
Noble. M., K. Murray, P. Stroobant, M. D. Waterfield, and P. Riddle. 1988. 
Platelet-derived growth factor promotes division and motility and inhibits 
premature differentiation of the 0ligodendrocyte/type-2 astrocyte progenitor 
cell. Naturl! (Lond.). 333:560-562. 
Panayotou, G., P. End, M. Aumailley. R. Timpl, andJ. Engel. 1989. Domains 
of 1aminin with growth-factor activity. CI!II. 56:93-101. 
Pruss, R. 1979. Thy-I antigen on astrocytes in long-term cultures of rat central 
nervous system. Nature (Lond.). 303:390-396. 
Raff, M. C. 1989. Glial cell diversification in the rat optic nerve. ScienCI! 
(Wash. DC). 243:1450-1455. 
Raff. M. C., K. L. Fields, S. Hakomori. R. Mirsky, R. M. Pruss, and J. Win-
ter. 1979. Cell-type-specific markers for distinguishing and studying neurons 
and the major classes of glial cells in culture. Brain Rl!s. 174:283-308. 
Raff, M. C .• R. H. Miller, and M. Noble. 1983. A glial progenitor cell that 
develops in vitro into an astrocyte or an oligodendrocyte depending on cul-
ture medium. Naturl! (Lond.). 303:390-396. 
Raff, M. C .• L. E. Lillien. W. D. Richardson, I. F. Burne, and M. Noble. 1988. 
Platelet-derived growth factor from astrocytes drives the clock that times 
oligodendrocyte development in culture. Narurl! (Lond.). 333:562-565. 
Ranscht, B., P. A. Clapshaw,J. Price, M. Noble, and W. Siefert. 1982. Devel-
opment of oligodendrocytes and Schwann cells studied with a monoclonal 
The IournaI of Cell Biology, Volume Ill. 1990 
antibody against galactocerebroside. Proc. Natl. Acad. Sci. USA. 79:2709_ 
2713. 
Richardson, W. D .• N. Pringle, M. J. Mosley, B. Westermark, and M. Dubois-
Dalcq. 1988. A role for platelet-derived growth factor in normal gliogenesis 
in the central nervous system. Cell. 53:309-319. 
Roberts, R. A., E. Spooncer, E. K. Parkinson, B. 1. Lord. T. D. Alien, and 
1. M. Dexter. 1987. Metabolically inactive 3T3 cells can substitute for mar-
row stromal cells to promote the proliferation and development of multipo_ 
tent haematopoietic stem cells. J. Cell. Physiol. 132:203-214. 
Rogelj, S., M. Klagsbrun, R. Atzmon, M. Kurokawa. A. Haimovitz. Z. Fuks, 
and 1. Vlodavsky. 1989. Basic fibroblast growth factor is an extracellular ma-
trix component required for supporting the proliferation of vascular en-
dothelial cells and the differentiation of PCI2 cells. J. Cell Bioi. 109:823-
831. 
Saksela, 0., D. Moscatelli, A. Sommer, and D. B. Rifkin. 1988. Endothelial 
cell-derived hcparan sui fate binds basic fibroblast growth factor and Protects 
it from proteolytic degradation. J. CI!II Bioi. 107:743-751. 
Stemple, D. L., N. K. Mahanthappa, and D. J. Anderson. 1988. Basic FGF 
induces neuronal differentiation, cell division, and NGF dependence in 
chromaffin cells: a sequence of events in sympathetic development. Nl!uron. 
1:517-525. 
Stockli. K. A., F. Lottspeich. M. Sendtner, P. Masiakowski, P. Carroll, R. 
Gotz. D. Lindholm, and H. Thoenen. 1989. Molecular cloning, expression 
and regional distribution of ciliary neurotrophic factor. Naturl! (Lond.). 
342:920-923. 
Temple, S., and M. C. Raff. 1985. Differentiation of a bipotential glial progeni-
tor cell in single cell microculture. Narurl! (Lond.). 313:223-225. 
Timpl, R., and H. Rohde. 1979. Laminin: a glycoprotein from basement mem-
branes. J. Bioi. Chl!m. 254:9933-9937. 
Vlodavsky, I., J. Folkman, R. Sullivan, R. Fridman, R. Ishai-Michaeli, J. 
Sasse, and M. Klagsbrun. 1987. Endothelial cell-derived basic fibroblast 
growth factor: synthesis and deposition into subendothelial cell extracellular 
matrix. Proc. Natl. Acad. Sci. USA. 84:2292-2296. 
WiIliarns, B. P., E. R. Abney. and M. C. Raff. 1985. Macroglial cell develop-
ment in embryonic rat brain: studies using monoclonal antibodies. fluores-
cence activated cell sorting and cell culture. Dl!v. Bioi. 112:126-134. 
, 
644 
